Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00832767 · ClinicalTrials.gov registry record · NA
SILS™ Port Laparoscopic Cholecystectomy Post Market Study
A NA study, sponsored by Medtronic - MITG.
- Completed
- Registry status
- NA
- Development phase
- 202
- Enrollment target
NCT00832767: Completed NA study, sponsored by Medtronic - MITG.
NCT00832767 is a NA study that has completed, run by Medtronic - MITG. The registered enrollment target is 202 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00832767, a NA study, has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- NA
- Development phase
- 202 participants
- Enrollment target
Study Summary
The objectives of this trial are: 1. to assess the feasibility and safety of performing SILS™ Port Laparoscopic Cholecystectomy 2. monitor and compare the outcomes of SILS™ Port Laparoscopic Cholecystectomy versus 4PLC to objectively document the scientific merit and the perceived advantages of SILS™ Port Laparoscopic Cholecystectomy.
Primary Outcome
Feasibility and safety as determined by intraoperative and postoperative adverse events.
Interventions
- PROCEDURE SILS™ port laparoscopic cholecystectomy
- PROCEDURE Four Port Laparoscopic Cholecystectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 202 participants |
| Start Date | 2009-04 |
| Est. Completion | 2012-01 |
| Phase | NA |
What the finished NCT00832767 record still lists
NCT00832767 is an interventional study that assigns participants to a tested intervention. The registered 202 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 2 interventions - of which SILS™ port laparoscopic cholecystectomy is the first listed.
NCT00832767 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00832767 about?
NCT00832767 is a clinical study titled "SILS™ Port Laparoscopic Cholecystectomy Post Market Study". The objectives of this trial are: 1. to assess the feasibility and safety of performing SILS™ Port Laparoscopic Cholecystectomy 2. monitor and compare the outcomes of SILS™ Port Laparoscopic Cholecystectomy versus 4PLC to objectively document the scientific merit and the perceived advantages of SIL...
What is the current status of trial NCT00832767?
This trial is currently completed. It is a NA study. The enrollment target is 202 participants. The study started on 2009-04. Estimated completion is 2012-01.
What interventions are being tested in trial NCT00832767?
The interventions under investigation include: SILS™ port laparoscopic cholecystectomy (PROCEDURE), Four Port Laparoscopic Cholecystectomy (PROCEDURE).
Who is sponsoring clinical trial NCT00832767?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00832767's enrollment target sits among peer trials
202 505th of 2000 higher than 1,495 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05272254 · 202 participants · Phase 2
Povidone Iodine Efficacy Study
- NCT05701280 · 202 participants · NA
Pilot/Pivotal Study of DBS+Rehab After Stroke
- NCT05932589 · 202 participants
Neurophysiologic Biomarkers in Rett Syndrome
- NCT06014931 · 202 participants · NA
Telehealth-enhanced Patient-oriented Recovery Trajectory After Intensive Care
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia